aPKC-iota promotes gallbaldder cancer tumorigenesis and gemcitabine-resistant by competing with Nrf2 for binding to Keap1
aPKC-iota promotes gallbaldder cancer tumorigenesis and gemcitabine-resistant by competing with Nrf2 for binding to Keap1
复制标题
aPKC-iota 通过与 Nrf2 竞争与 Keap1 的结合来促进胆囊癌肿瘤发生和吉西他滨耐药
作者:
Li Tian;Yun Lu;Tao Yang;Zhengdong Deng;Lei Xu;Wei Yao;Chaoqun Ma;Xiangyu Li;Jian Zhang;Yan Liu;Jianming Wang